肝素对血源抗菌化合物的中和作用:对抗菌活性和炎症反应的影响
Denisa Cont1,2, Stephan Harm1, Claudia Schildböck1
1Department for Biomedical Research, University for Continuing Education Krems, Krems an der Donau, Austria.
Frontiers in immunology
|April 8, 2024
概括
未分离的氨酸显著降低了血源抗微生物化合物 (AMC) 的抗微生物和内毒素中和能力. 这种由肝素诱导的AMC抑制导致炎症反应增加和体外细菌负载增加.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血源抗微生物化合物 (AMC) 对天生的免疫力至关重要,清除病原体和中和内毒素.
- 通过抑制内毒素-脂多糖 (LPS) 与免疫细胞的相互作用,AMCs可以预防过度炎症.
- 不分离的肝素是一种抗凝剂,广泛使用,但其对AMC的影响尚未完全理解.
研究的目的:
- 为了研究未分离的肝素对血源AMCs的内毒素中和抗菌活性的影响.
- 为了确定肝素是否影响AMCs和LPS介导的炎症反应.
- 探索对AMC隔离和表征的潜在影响.
主要方法:
- 来自健康捐赠者的血清样本被预化以不同度和持续时间的未分离肝素.
- 预化样本进行了针对常见病原体 (如Acinetobacter baumannii,Pseudomonas aeruginosa) 的抗菌活性测试.
- 使用来自*E. coli*,*K. pneumoniae*和*P. aeruginosa*的LPS评估了内毒素中和能力,并测量了促炎性细胞因子TNF-α和IL-6的测量.
主要成果:
- 氨酸证明了血液衍生的AMCs活动的剂量依赖性下降.
- 肝素的预化导致LPS活性增强和TNF-α和IL-6水平升高.
- 在存在氨酸时,观察到测试的致病细菌 (*A. baumannii*, *E. coli*, *K. pneumoniae*, *P. aeruginosa*) 的度增加.
结论:
- 未分离的肝素中和血液衍生的AMCs的活性 *在体外*.
- 肝素对AMCs的这种抑制作用可能会损害宿主的先天免疫反应.
- 研究结果表明,有可能开发用于AMC隔离和表征的新型亲和力技术,利用肝素的相互作用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
Antimicrobial Proteins
984
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
984
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Factors Affecting Protein-Drug Binding: Drug Interactions
139
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
139


